In vivo imaging

Advanced in vivo imaging using BLI, FLI, CT and 3D imaging enables longitudinal monitoring of disease progression throughout preclinical studies.

Preclinical in vivo imaging overview

In vivo imaging provides valuable insights into biological processes and disease progression in living organisms. At IVRS, we specialize in comprehensive preclinical in vivo imaging services using BLI, CT and 3D imaging to visualize, monitor and analyze biological processes longitudinally.

IVRS uses advanced preclinical imaging technologies, including 2D and 3D bioluminescence and fluorescence imaging, as well as CT to visualize and quantify biological processes in vivo.

Longitudinal disease monitoring Monitor disease progression and biological changes over time in the same subject, reducing reliance on endpoint-only measurements.

Reduced variability and animal use Repeated measurements in the same subject help reduce inter-animal variability and the number of animals required.

Drug response assessment Visualize and quantify treatment effects over time to support preclinical drug efficacy studies and informed development decisions.

Multimodal imaging read-outs Combine 2D and 3D bioluminescence and fluorescence imaging with CT for complementary anatomical and functional read-outs.

Key capabilities

Effective therapies

Accelerating preclinical drug development

Longitudinal in vivo imaging enables researchers to monitor disease progression and therapeutic effects over time, supporting faster and more informed decisions in preclinical drug development.

Explore how IVRS in vivo imaging services can support your preclinical research and drug development program.

In vivo research services

Preclinical in vivo capabilities

In vivo imaging

Advanced in vivo imaging for longitudinal monitoring of disease progression and treatment response.

Drug validation

Preclinical drug validation to assess therapeutic potential, biological activity and treatment response.

Drug efficacy

In vivo drug efficacy studies to evaluate therapeutic response, dose effects and treatment outcomes.

Biodistribution studies

Biodistribution studies to track drug delivery, tissue distribution and target-specific accumulation in vivo.

Toxicology assessment

Preclinical toxicology studies to evaluate drug safety, tolerability and potential adverse effects.

Preclinical study design

Customized preclinical study design tailored to disease models, therapeutic targets and drug development goals.

Let us help you to thrive

Do you want to learn more about our work and how we can help you?